JK

John King-Underwood

RE Respivert: 7 patents #1 of 28Top 4%
TL Topivert Pharma Limited: 2 patents #1 of 19Top 6%
📍 Ledbury, GB: #1 of 3 inventorsTop 35%
Overall (2016): #14,181 of 481,213Top 3%
7
Patents 2016

Issued Patents 2016

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
9475796 1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors Kazuhiro Ito, Catherine Elisabeth Charron, Stuart Thomas Onions, Alistair Ian Longshaw 2016-10-25
9447076 Inhibitor of p38 map kinase Alistair Ian Longshaw, Euan Alexander Fraser Fordyce, Stuart Thomas Onions, Jennifer D. Venable 2016-09-20
9340545 Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitors Kazuhiro Ito, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2016-05-17
9321773 Compounds Kazuhiro Ito, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2016-04-26
9260410 P38 MAP kinase inhibitors Kazuhiro Ito, Peter Strong, William Garth Rapeport, Catherine Elisabeth Charron, Peter John Murray +2 more 2016-02-16
9249125 Pyrazole derivatives as p38 MAP inhibitors Lorna Duffy, Alistair Ian Longshaw, Peter John Murray, Stuart Thomas Onions, David Michael Adrien Taddei +3 more 2016-02-02
9242960 P38MAP kinase inhibitors Kazuhiro Ito, Peter Strong, William Garth Rapeport, Peter John Murray, Jonathan Gareth Williams +2 more 2016-01-26